Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
PCSA
|
James E Besser |
BUY
Open market or private purchase
|
Direct | 30,000 Added 6.9% |
$121,200
$4.04 p/Share
|
Oct 02
2020 |
HCAT
|
D Fraser Bullock |
SELL
Open market or private sale
|
Direct | 1,700 Reduced 2.46% |
$62,917
$37.01 p/Share
|
Oct 02
2020 |
HCAT
|
Daniel H. Orenstein
General Counsel |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.23% |
$18,505
$37.01 p/Share
|
Oct 02
2020 |
HCAT
|
Daniel H. Orenstein
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 500 Added 1.22% |
$5,170
$10.34 p/Share
|
Oct 02
2020 |
CRVL
|
V Gordon Clemons |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.14% |
$87,200
$87.2 p/Share
|
Oct 02
2020 |
LSCC
|
Sherri R Luther
SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,376 Reduced 4.67% |
$123,491
$28.22 p/Share
|
Oct 02
2020 |
LSCC
|
Sherri R Luther
SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 8,824 Added 8.6% |
-
|
Oct 02
2020 |
SNX
|
Kevin M Murai
Director |
SELL
Bona fide gift
|
Indirect | 1,390 Reduced 1.0% |
-
|
Oct 02
2020 |
EPAY
|
Richard Douglas Booth
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,100 Reduced 0.98% |
$46,354
$42.14 p/Share
|
Oct 02
2020 |
EPAY
|
Norman J Deluca
MD of Banking Solutions |
SELL
Open market or private sale
|
Direct | 870 Reduced 0.91% |
$36,662
$42.14 p/Share
|
Oct 02
2020 |
EPAY
|
Robert A Eberle
President & CEO |
SELL
Open market or private sale
|
Direct | 5,209 Reduced 1.13% |
$219,507
$42.14 p/Share
|
Oct 02
2020 |
EPAY
|
John Francis Kelly
GM, Legal Solutions |
SELL
Open market or private sale
|
Direct | 326 Reduced 0.53% |
$13,738
$42.14 p/Share
|
Oct 02
2020 |
EPAY
|
Nigel K Savory
Managing Director Europe |
SELL
Open market or private sale
|
Direct | 1,442 Reduced 0.88% |
$60,766
$42.14 p/Share
|
Oct 02
2020 |
LOVE
|
Shirley Romig
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,868 Added 50.0% |
-
|
Oct 02
2020 |
ELV
|
Peter D Haytaian
EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct | 4,667 Reduced 10.66% |
$1,306,760
$280.0 p/Share
|
Oct 02
2020 |
ELV
|
Peter D Haytaian
EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct | 4,667 Added 9.64% |
$443,878
$95.11 p/Share
|
Oct 02
2020 |
ICD
|
John A. Gallegos Jr.
PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 956 Reduced 3.13% |
-
|
Oct 02
2020 |
ICD
|
John A. Gallegos Jr.
PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,929 Added 11.41% |
-
|
Oct 02
2020 |
ICD
|
James Minmier |
BUY
Exercise of conversion of derivative security
|
Direct | 353 Added 7.08% |
-
|
Oct 02
2020 |
AINC
|
Monty J Bennett
CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct | 4,430 Added 4.03% |
-
|
Oct 02
2020 |
HOOK
|
Capital Vi Fcpr Sofinnova
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.01% |
$3,000
$10.0 p/Share
|
Oct 02
2020 |
HGBL
|
Topline Capital Partners, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 848,937 Added 16.3% |
$1,519,597
$1.79 p/Share
|
Oct 02
2020 |
HGBL
|
Topline Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 848,937 Added 8.38% |
$1,519,597
$1.79 p/Share
|
Oct 02
2020 |
KOSS
|
Michael J Koss
President and CEO |
SELL
Other acquisition or disposition
|
Indirect | 44,000 Reduced 27.65% |
-
|
Oct 02
2020 |
KOSS
|
Michael J Koss Jr
VP - Marketing & Product |
BUY
Other acquisition or disposition
|
Direct | 44,000 Added 48.89% |
-
|
Oct 02
2020 |
JSD
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 33,926 Added 2.73% |
$419,325
$12.36 p/Share
|
Oct 02
2020 |
FSTR
|
William Treacy
EVP & Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 356 Reduced 2.83% |
$4,977
$13.98 p/Share
|
Oct 02
2020 |
GHL
|
Steven F Goldstone
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,753 Added 4.8% |
-
|
Oct 02
2020 |
GHL
|
Karen P Robards
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,377 Added 5.46% |
-
|
Oct 02
2020 |
GHL
|
John D Liu |
BUY
Grant, award, or other acquisition
|
Direct | 1,377 Added 6.76% |
-
|
Oct 02
2020 |
GHL
|
Meryl D Hartzband |
BUY
Grant, award, or other acquisition
|
Direct | 3,084 Added 13.41% |
-
|
Oct 02
2020 |
ARAY
|
Shigeyuki Hamamatsu
SVP & CFO |
SELL
Open market or private sale
|
Direct | 8,641 Reduced 4.65% |
$20,998
$2.43 p/Share
|
Oct 02
2020 |
ARAY
|
Joshua Levine
CEO |
SELL
Open market or private sale
|
Direct | 15,370 Reduced 1.97% |
$37,349
$2.43 p/Share
|
Oct 02
2020 |
OOMA
|
Ravi Narula
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 15,000 Added 5.9% |
-
|
Oct 02
2020 |
BLUE
|
Philip D Gregory
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 60 Reduced 0.17% |
$3,166
$52.77 p/Share
|
Oct 02
2020 |
BLUE
|
Nick Leschly |
SELL
Open market or private sale
|
Direct | 450 Reduced 0.45% |
$23,747
$52.77 p/Share
|
Oct 02
2020 |
BLUE
|
Alison Cecily Finger
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 36 Reduced 0.13% |
$1,900
$52.77 p/Share
|
Oct 02
2020 |
BLUE
|
Joanne Smith Farrell
COO, Oncology |
SELL
Open market or private sale
|
Direct | 38 Reduced 0.17% |
$2,005
$52.77 p/Share
|
Oct 02
2020 |
BLUE
|
Jason Cole
Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct | 38 Reduced 0.11% |
$2,005
$52.77 p/Share
|
Oct 02
2020 |
BLUE
|
David Davidson
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 64 Reduced 0.16% |
$3,377
$52.77 p/Share
|
Oct 02
2020 |
JRO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 28,905 Added 0.66% |
$236,732
$8.19 p/Share
|
Oct 02
2020 |
RLGT
|
Bohn H Crain
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,463 Reduced 0.23% |
$12,438
$5.05 p/Share
|
Oct 02
2020 |
RLGT
|
Bohn H Crain
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,389 Added 0.68% |
$4,433
$0.6 p/Share
|
Oct 02
2020 |
TIPT
|
Michael Gene Barnes
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 2,803 Added 0.03% |
$13,791
$4.92 p/Share
|
Oct 02
2020 |
JFR
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,600 Added 0.05% |
$29,988
$8.33 p/Share
|
Oct 02
2020 |
LQDT
|
William P Angrick Iii
Chairman of the Board and CEO |
BUY
Open market or private purchase
|
Indirect | 45,373 Added 0.83% |
$336,668
$7.42 p/Share
|
Oct 02
2020 |
SFIX
|
Scott Darling
Chief Legal Officer & Secr. |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 2.86% |
$54,760
$27.38 p/Share
|
Oct 02
2020 |
RMNI
|
David W. Rowe
CPO,CMO&EVPGlob.Transformation |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 5.41% |
$11,900
$1.19 p/Share
|
Oct 02
2020 |
MOD
|
Brian Jon Agen
VP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct | 16,387 Added 19.34% |
-
|
Oct 02
2020 |
MOD
|
Scott L Bowser
VP, CIS and COO |
BUY
Grant, award, or other acquisition
|
Direct | 49,063 Added 17.69% |
-
|
Oct 02
2020 |